Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Feb 23, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Reminder: NIH Natural Disaster Policy Winter Storms
National Institutes of Health
General Notices
- NIBIB Guidance for Support of Clinical Trial Applications
National Institute of Biomedical Imaging and Bioengineering
- Notice Announcing the National Human Genome Research Institutes Expectation for Sharing Quality Metadata and Phenotypic Data
National Human Genome Research Institute
- Request for Information (RFI): Leveraging Clinical Trial Populations in NCIs National Clinical Trial Network (NCTN) and Community Oncology Research Program (NCORP) for Observational Cancer Survivorship Studies
National Cancer Institute
Notice of Changes to Funding Opportunities
- Notice of Early Expiration of NOT-AI-20-065 Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
National Institute of Allergy and Infectious Diseases
- Notice of Change to Key Dates in RFA-CA-21-001, "Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)"
National Cancer Institute
- Notice of NIDDK Participation in PAR-19-274, "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)"
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of NIBIB Participation in PA-20-262, "PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
National Institute of Biomedical Imaging and Bioengineering
- Notice of NIBIB Participation in PA-20-183, "Research Project Grant (Parent R01 Clinical Trial Required)"
National Institute of Biomedical Imaging and Bioengineering
- Notice of NIBIB Participation in PA-20-261, "PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"
National Institute of Biomedical Imaging and Bioengineering
- Notice of Termination of RFA-FD-21-023 "National Food and Nutrient Analysis Program (U01) Clinical Trial Not Applicable"
Food and Drug Administration
- Notice of Change to Key Dates for PAR-21-115 "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Early Expiration for PAR-19-337 "Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional)"
National Center for Advancing Translational Sciences
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Research Grants for the Metabolic Dysregulation and Cancer Risk Program: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: a Transdisciplinary Approach to Obesity-associated Research (U01 Clinical Trial Not Allowed)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics]
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Translation of Quantitative Imaging tools and Methods for the Academic Industrial Partnership
National Cancer Institute
- Notice of Special Interest (NOSI): Hearing Healthcare for Adults: Improving Access and Affordability
National Institute on Deafness and Other Communication Disorders
- Notice of Special Interest (NOSI): National Research Service Award (NRSA) F32 Postdoctoral Fellowship Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities
National Eye Institute
National Institute on Deafness and Other Communication Disorders
- Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies
National Institute of General Medical Sciences
Funding Opportunities
- Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
- Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional)
John E. Fogarty International Center
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
- The FDA's Cooperative Agreement Program for States and Territories to Implement a National Produce Safety Program (U2F) Clinical Trials Not Allowed
Limited to only one application allowed per state/territory.
Food and Drug Administration
- Drug Development Tools Research Grants (U01) Clinical Trial Optional
Food and Drug Administration
- Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration
- Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
National Cancer Institute
- Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
- Renewal : UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (U01) Clinical Trials Optional
Food and Drug Administration
- Dermal Physiologically-based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-solvent following the Application of Generic Dermatological Products (U01) Clinical Trial Optional
Food and Drug Administration
- Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD) (U01) Clinical Trial Required
Food and Drug Administration
- Training Alliance to Enhance Produce Safety and FDA Food Safety Modernization Act Compliance (U2F) Clinical Trial Not Allowed
Food and Drug Administration
- Alliance to Support Integrated Public Health System Activities (U2F) Clinical Trials Not Allowed
Food and Drug Administration
- Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required
Food and Drug Administration
- Tobacco Regulatory Science (R01 Clinical Trial Optional)
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu.